WAS
WST icon

WESPAC Advisors SoCal’s West Pharmaceutical WST Stock Holding History

WESPAC Advisors SoCal’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-74
Closed -$8K – 317
2019
Q1 		$8K Hold
74
– – ﹤0.01% 256
2018
Q4 		$7K Buy
+74
New +$8.03K ﹤0.01% 268

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WESPAC Advisors SoCal's WST Position: Q2 2019 in Review

WESPAC Advisors SoCal sold out of West Pharmaceutical (WST) in Q2 2019, closing a stake of 74 shares — an estimated $8K sold.

WESPAC Advisors SoCal first reported a position in WST in Q4 2018 and held it in 2 quarters. The position peaked at $8K in Q1 2019. 374 funds tracked by Wall St. Rank hold WST as of Q2 2019.

  • WESPAC Advisors SoCal reported no remaining West Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • WESPAC Advisors SoCal sold 74 West Pharmaceutical shares in Q2 2019, an estimated $8K.
  • WESPAC Advisors SoCal first reported a position in West Pharmaceutical in Q4 2018 and held it in 2 quarters.
  • WESPAC Advisors SoCal's West Pharmaceutical position peaked at $8K in Q1 2019.
  • 374 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2019.

Based on WESPAC Advisors SoCal's 13F filing for Q2 2019, filed 30 Jul 2019.